Tag
When it comes to COVID-19 vaccines, Americans want to know more about safety and potential side-effects (including any possible long-term…

The World Health Organization (WHO) currently estimates that ending the COVID-19 pandemic will require at least 70% of the world’s…

A new New York Times perspective piece on whether we’re underselling the various COVID-19 vaccines had public health Twitter abuzz…

Journalists covering the COVID-19 vaccine rollout should watch out on Jan. 21 for the Ad Council’s unveiling of an advertising…

Pfizer made waves Monday with its announcement that its COVID-19 vaccine, developed with partner BioNTech, is “strongly effective,” with a…

Photo: Photo: VCU Capital News Service via Flickr The race for a COVID-19 is heating up. At least two COVID-19…

I’ve written in previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The…

It’s been a dizzying task for reporters trying to keep up with the development of COVID-19 vaccines. There are the…

The timeless advice sometimes attributed to Deep Throat or Bob Woodard and Carl Bernstein to “follow the money” certainly applies…

As various COVID-19 vaccine candidates make their way through clinical trials — see this nice update on where things stand…
